BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20107195)

  • 1. Dietary, lifestyle, and clinical predictors of lipoprotein-associated phospholipase A2 activity in individuals without coronary artery disease.
    Hatoum IJ; Nelson JJ; Cook NR; Hu FB; Rimm EB
    Am J Clin Nutr; 2010 Mar; 91(3):786-93. PubMed ID: 20107195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein-associated phospholipase A2 activity is associated with coronary artery disease and markers of oxidative stress: a case-control study.
    Kim JY; Hyun YJ; Jang Y; Lee BK; Chae JS; Kim SE; Yeo HY; Jeong TS; Jeon DW; Lee JH
    Am J Clin Nutr; 2008 Sep; 88(3):630-7. PubMed ID: 18779277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
    Mohler ER; Ballantyne CM; Davidson MH; Hanefeld M; Ruilope LM; Johnson JL; Zalewski A;
    J Am Coll Cardiol; 2008 Apr; 51(17):1632-41. PubMed ID: 18436114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking induces lipoprotein-associated phospholipase A2 in cardiovascular disease free adults: the ATTICA Study.
    Tselepis AD; Panagiotakos DB; Pitsavos C; Tellis CC; Chrysohoou C; Stefanadis C
    Atherosclerosis; 2009 Sep; 206(1):303-8. PubMed ID: 19394616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial variation in lipoprotein-associated phospholipase A₂ in older adults.
    Lee KK; Fortmann SP; Varady A; Fair JM; Go AS; Quertermous T; Hlatky MA; Iribarren C
    BMC Cardiovasc Disord; 2011 Jun; 11():38. PubMed ID: 21714927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dietary factors on lipoprotein-associated phospholipase A(2) (Lp-PLA (2)).
    Wong CK; White HD
    Curr Atheroscler Rep; 2011 Dec; 13(6):461-6. PubMed ID: 21870060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein-associated phospholipase A2 mass is significantly reduced in dyslipidemic patients treated with lifestyle modification and combination lipid-modifying drug therapy.
    Reddy KJ; Singh M; Batsell RR; Bangit JR; Miraskar RA; Zaheer MS
    Prev Cardiol; 2010; 13(3):130-4. PubMed ID: 20626668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein-associated phospholipase A2 (Lp-PLA2) and future risk of type 2 diabetes: results from the Cardiovascular Health Study.
    Nelson TL; Biggs ML; Kizer JR; Cushman M; Hokanson JE; Furberg CD; Mukamal KJ
    J Clin Endocrinol Metab; 2012 May; 97(5):1695-701. PubMed ID: 22399516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein-associated phospholipase A(2) bound on high-density lipoprotein is associated with lower risk for cardiac death in stable coronary artery disease patients: a 3-year follow-up.
    Rallidis LS; Tellis CC; Lekakis J; Rizos I; Varounis C; Charalampopoulos A; Zolindaki M; Dagres N; Anastasiou-Nana M; Tselepis AD
    J Am Coll Cardiol; 2012 Nov; 60(20):2053-60. PubMed ID: 23083783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
    Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Liamis GL; Kakaidi B; Tselepis AD; Cariolou MA; Elisaf MS
    Arch Med Res; 2007 May; 38(4):403-10. PubMed ID: 17416287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipase A2 enzymes, high-dose atorvastatin, and prediction of ischemic events after acute coronary syndromes.
    Ryu SK; Mallat Z; Benessiano J; Tedgui A; Olsson AG; Bao W; Schwartz GG; Tsimikas S;
    Circulation; 2012 Feb; 125(6):757-66. PubMed ID: 22230483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein-associated phospholipase A2, hormone use, and the risk of ischemic stroke in postmenopausal women.
    Wassertheil-Smoller S; Kooperberg C; McGinn AP; Kaplan RC; Hsia J; Hendrix SL; Manson JE; Berger JS; Kuller LH; Allison MA; Baird AE
    Hypertension; 2008 Apr; 51(4):1115-22. PubMed ID: 18259035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein-associated phospholipase A(2) and risk of congestive heart failure in older adults: the Cardiovascular Health Study.
    Suzuki T; Solomon C; Jenny NS; Tracy R; Nelson JJ; Psaty BM; Furberg C; Cushman M
    Circ Heart Fail; 2009 Sep; 2(5):429-36. PubMed ID: 19808373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of statin therapy on lipoprotein associated phospholipase A2 levels.
    Albert MA; Glynn RJ; Wolfert RL; Ridker PM
    Atherosclerosis; 2005 Sep; 182(1):193-8. PubMed ID: 15982658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein-associated phospholipase A2 concentrations in plasma are associated with the extent of coronary artery disease and correlate to adipose tissue levels of marine n-3 fatty acids.
    Schmidt EB; Koenig W; Khuseyinova N; Christensen JH
    Atherosclerosis; 2008 Jan; 196(1):420-424. PubMed ID: 17157859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated plasma lipoprotein-associated phospholipase A₂ activity is associated with plaque rupture in patients with coronary artery disease.
    Liu CF; Qin L; Ren JY; Chen H; Wang WM; Liu J; Song JX; Li LJ
    Chin Med J (Engl); 2011 Aug; 124(16):2469-73. PubMed ID: 21933589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution and correlates of lipoprotein-associated phospholipase A2 in an elderly cohort: the Cardiovascular Health Study.
    Furberg CD; Nelson JJ; Solomon C; Cushman M; Jenny NS; Psaty BM
    J Am Geriatr Soc; 2008 May; 56(5):792-9. PubMed ID: 18363676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of lipoprotein-associated phospholipase A2 with coronary artery disease in African-Americans and Caucasians.
    Anuurad E; Ozturk Z; Enkhmaa B; Pearson TA; Berglund L
    J Clin Endocrinol Metab; 2010 May; 95(5):2376-83. PubMed ID: 20194707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention.
    Anderson JL
    Am J Cardiol; 2008 Jun; 101(12A):23F-33F. PubMed ID: 18549868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein-associated phospholipase A2 activity improves risk discrimination of incident coronary heart disease among women.
    Hatoum IJ; Cook NR; Nelson JJ; Rexrode KM; Rimm EB
    Am Heart J; 2011 Mar; 161(3):516-22. PubMed ID: 21392606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.